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Previous studies have demonstrated alterations in pol-
ymorphonuclear leukocyte (PMNL) function in patients 
with psoriasis, but results have been variable. In this 
study we attempted to determine whether functional 
changes in PMNL from psoriatics represented an intrin-
sic cellular defect or a response to factors in serum. We 
evaluated the effect of the continuous presence of au-
tologous and heterologous serum on lysozyme release 
and superoxide anion (02 -) generation by psoriatic and 
normal PMNL exposed to a soluble or particulate phag-
ocytic stimulus. There were no differences in 02- gen-
eration or lysozyme release between normal and pso-
riatic PMNL without serum. However, in the presence 
of 10% autologous serum, these responses were signifi-
cantly decreased for psoriatic PMNL (p < .001). The 
results were not time-dependent and did not correlate 
with the extent of psoriatic involvement. The data sup-
port the hypothesis that serum factors exist in patients 
with psoriasis that may affect PMNL functions. The 
presence or absence of such factors could explain, in 
part, the differences between the various investigations 
of PMNL function in psoriasis. 
Several studies have demonstrated alterations in granulocyte 
function in patients with psoriasis. These changes include 
enhancement of granulocyte adherence (1], random migration 
(2], chemotaxis [3], phagocytosis [3], antibody-dependent cell-
mediated cytotoxicity [4], and hexose monophosphate shunt 
activity [ 5]. Since these alterations are not always correlated 
with activity or extent of disease, it is not clear that they are 
secondary to epidermal hyperprofileration. Moreover, it is not 
possib le to assign an etiologic role to such findings since while 
polymorphonuclear leukocytes (PMNL) may be present in 
dermal and epidermal inflammatory infiltrates of psoriatic 
lesions, mononuclear cells usually predominate, and clinical 
pustu lation is exceptionaL 
In the present studies, we attempted to further characterize 
the functional changes in PMNL from psoriatics and to deter-
mine whether they represent an intrinsic cellular defect(s) or a 
response to soluble circulating factor(s) in serum. Thus we 
measured the effect of the continuous presence of autologous 
and heterologous serum on the responses of psoriatic and 
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Abbreviations: 
HETEs: monohydroxyeicosatetraenoic ac ids 
LDH: lactic dehydrogenase 
NBT: nitroblue tetrazolium 
0 " - , superox ide anion 
PMA: phorbol myrisate acetate 
PMNL: polymorphonuclear leukocyte(s) 
PiCM: buffered salt solution of 138 mM NaCI, 2.7 mM KCI, 8. 1 
mM NazHPO,, 1.5 mM KH 2 PO.,, 1.0 mM MgC1 2, and 0.6 mM CaC12, 
pH 7.4 
Z: opsonized zymosan 
normal PMNLs to a soluble and particulate phagocytic stimu-
lus, phorbol myristate acetate (PMA) and opsonized zymosan 
(Z), respectively. The following parameters were evaluated: 
superoxide anion (02 - ) generation, percent lysozyme release, 
and the rate of phagocytosis. 
MATERIALS AND METHODS 
Subjects 
Patients seen at the Ohio State University Hospital Dermatology 
Clinic with psoriasis diagnosed by established clinical and histo-
pathologic criteria were asked to participate. Healthy laboratory per-
sonnel with no personal or immediate family history of psoriasis served 
as paired controls. Informed consent was obtained from all subjects. 
No subject was receiving systemic medications, but some psoriatics 
were using topica l medications (corticosteroids, coal tar products, an-
thralin). 
Preparation. of Cell. Suspensions and Serum 
Fifty milliliters of heparinized (10 U/mll venous blood was obtained 
from subjects by venipuncture. Purified preparations of PMNL were 
isolated by means of Hypaque-Ficoll gradients followed by dextran 
sedimentation and hypotonic lysis of erythrocytes. This method yie lded 
100- 200 X 10" PMNL depending upon the peripheral leukocyte count. 
Viability determined by trypan blue exclusion was 98 ± 2%. The cells 
were suspended in a buffered salt solut ion consisting of 138 mM NaCJ, 
2.7 mM KCI, 8.1 mM Na2HPO . ., 1.5 mM KHzPO . ., 1.0 mM MgCI2, and 
0.6 mM CaCI2 , pH 7.4 (hereafter referred to as PiCM). 
Whole blood was withdrawn simultaneously and allowed to clot at 
room temperature for 30 min. Serum was separated by centrifugation 
at 3000 rpm for 15 min and used the same day. 
PMNL from psoriatic donors were always studied with a paired 
normal control donor. Autologous serum refers to the donor's serum 
on the day of t he experiment. 
Preparation of Phagocytic Stimuli 
Zymosan A (S igma) was opsonized by incubating with fresh se rum 
(5 mg/ml) from a different normal donor for 15 min at 37"C, vort.exing 
for 5 min , centrifuging, and restoring the original concentration in 
PiCM. PMA (Consolidated Midland Corp., Brewster, New York) was 
dissolved in dimethyl sulfoxide a nd used at a final concentration of 0.2 
11g/ml. 
S u.peroxide Anion Production 
Washed PMNL (1 X 106) in 0.8 ml PiCM were preincubatetl wit h 
serum (final concentration 10%) for 15 min at 37"C in sterile plastic 
test tubes. Cytochrome C, horse hea rt, type III solut ion (Sigma Chem-
ical Co., St. Louis, Missouri) , 0.9 mg in 0.1 ml PiCM was added to all 
tubes just prior to stimulation. Ten microli ters of superoxide dismutase 
solution (Miles Biochemicals, Elkhart, Indiana), 1 mg/ml, was added 
to one tube in each triplicate to serve as control for nonspecific 
reduction of' cytochrome C. The stimu lus solut ion or PiCM (0.1 ml) 
was added at zero time to obtain a final volume of 1.0 ml in the 
stimulated and unstimulated reaction mixtures. After an additional 15 
min at 37"C, the cell suspensions were centrifuged at 4"C. Reduced 
cytochrome C in the cold cell -free supernates was measured at 550 nm 
on a spectrophotometer (Model DU-7, Beckman Instruments, Novi, 
Michigan) and quanti tated using t he extinction coefficient 21.1 
mM -'cm- • (reduced-oxidized). 0 2- generation is expressed as nmol 
cytochrome C reduced per 1 x 106 PMNL per 15 min . 
Lysozyme Release 
Washed PMNL (3 X 10") in 0.9 ml PiCM were preincubated with 
serum (final concentration, 10%) for 15 min at 37"C followed by 
addition of 0.1 ml stimulus solu t ion or buffe r. After an additional 15 
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min, the cell suspensions were centri tuged and aliquots of the medium 
were assayed for lysozyme [6) and lactic dehydrogenase (LDH) activi-
t ies. Cell viabi li ty was assessed by measuring leakage of the cytosolic 
enzyme LDH . Results are expressed as the percentage of total cellular 
enzyme released into the medium by Triton X-100 (0.2 % v/v) . 
Phagocytosis 
The rate of phagocytosis by PMNL of opsonized, lipopolysaccharide-
coated paraffin oil droplets contain ing oi l-red-O was measured accord-
ing to the method described by Stossel [7]. Results are expressed as 
milligrams of oi l-red-O ingested per min per 1 X 107 PMNL. 
Statistics 
If not mentioned otherwise, mean values and standard deviations 
are shown. Data were ana lyzed by Student's t-test (two-tailed) where 
statistical significnce was defined by a p value of less than 0.05. 
RESULTS 
Superoxide Anion Generation 
Psoriatic PMNL + 10% autologous serum generated signifi-
cantly less 0 "- compared to normal PMNL + 10% autologous 
serum (p < .001) when eit her PMA or Z was used as stimulus 
(Fig 1). Psoriatic or normal cells incubated with heterologous 
serum produced comparable intermediate levels of 0~ - . Normal 
PMNL + heterologous psoriatic serum produced significantly 
less o~- t ha n normal PMNL + autologous serum (p < .001) , 
and o~- production was significa ntly increased for psoriat ic 
PMNL + heterologous normal serum compared to psoriatic 
PMNL + autologous serum (p < .001) . While variability is seen 
in t he resul ts of 0 2- generation among indivdiuals (Fig 2), it 
should be noted t hat in every experiment (n = 17) the same 
t rend was found: normal PMNL + normal serum > normal 
PMNL + psoriatic serum :::= psoriatic PMNL + normal serum 
>psoriatic PMNL +psoriatic serum. There were no differences 
in baseline 0 2- generation in any of t he four mixtures (Fig 1). 
Decreased o~- generat ion by psoriatic PMNL incubated with 
autologous serum compared to normal serum showed no cor-
relation with t he estimated extent of disease (Table 1). 
To evaluate whether t he results are due to effects of the 
disease on serum or cells or both, a group of normal a nd 
psoriatic subjects' neutrophils were studied± autologous serum 
± stimulus (Fig 3). There were no signficant differences in 0 "-
generation between normal and psoriatic PMNL without 
serum. When autologous serum is added, both types of cells 
demonstrate enhanced o2- generation; however, that of normal 
cells + serum is significa nt ly increased compared to psoriatic 
PMNL + serum when either PMA or Z serves as stimulus. 
To determine whether the effect of serum on 0 2 - generation 
is t ime-dependent , we incubated normal and psoriatic PMNL 
with heterologous serum for variable time intervals from 0-60 
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FIG 1. Cytochrome C reduction by normal and psoriatic PMNL 
incubated with 10% autologous or heterologous serum after stimulation 
with buffer, PMA, or opsonized zymosan. 
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TABLE I. Mean. and range of cytochrome C reduction by PM A-
stimulated psoriatic PM NL incubated with. 10% serum 
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FIG 3. Cytochrome C reduction by normal and psoriatic PMNL 
with and without 10o/c autologous serum after stimulation with buffer, 
PMA, or opsonized zymosan (Z). NS (not significant) and p values 
compare pso riatics and paired normals fo r each stimulus. 
min. In 8 experiments, no consistent effect of prolonged prein-
cubation t ime was found (data not shown). 
Lyso2yme Release 
Results paralleled t hose for 0 1- generation (Fig 4). Normal 
PMNL + autologous serum released significantly more lyso-
zyme t han psoriatic PMNL + auto logous serum with either 
stimulus, p < .001. Differences between cells + autologous 
serum and cells + heterologous serum did not attain statistical 
significance. However, t he same trend was obtained in each 
experiment (n = 7): normal PMNL + autologous serum > 
normal PMNL + psoriatic serum > psoriatic PMNL + normal 
serum >psoriatic serum + autologous serum. LDH release was 
less than 5% of total cellular enzyme in each experiment. 
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Phagocytosis 
The rate of ingestion of oil-red-O by normal PMNL (n = 14) 
was not different when compared to psoriatic PMNL (n = 8), 
.094 vs .098 mg/min/107 PMNL (Fig 5). 
DISCUSSION 
Previous investigations of PMNL function in psoriatic pa-
tients and the effects of their serum on function have had 
variable results. These differences appear to reflect study tech-
nique, patient population, and whether or not PMNL were 
preincubated with serum. Thus, PMNL of psoriatic patients 
have been reported to have increased [8] or normal [2,9] chem-
otaxis to endotoxin-activated serum, and these results did not 
correlate with activity of the disease. 
Evaluation of the oxygen metabolism of PMNL from pso-
riatics has also produced divergent results. Using chemilumi-
nescence as a measure of t he generation of the reactive oxygen 
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species, hydrogen peroxide, superoxide anion, hydroxyl radical , 
and singlet oxygen, Schopf et al [10] found enhanced generation 
of these products by both PMNL and monocytes of psoriat ic 
patients. On the other hand, Camisa et al [11] found no 
difference in superoxide generation between psoriatics and 
normal controls as measured by superoxide dismutase inhibit-
able cytochrome C reduction . Resting nitroblue tetrazolium (NBT) reduction was normal for psoriatic PMNL, but 48-h 
cultures of peripheral blood mononuclear cells gave enhanced 
spontaneous NBT reduction [12]. When 10% normal plasma 
was added to these cultures NBT reduction was decreased by 
50%, but addition of psoriatic plasma had no effect [12] . 
Sedgwick et al [13,14] also studied the effects of psoriatic 
serum on o~- generation by normal PMNL. They found in-
creased and decreased o"- generation by normal cells stimulted 
by Z and PMA, respectively. The apparent difference in our 
results with zymosan can be explained by different methods of 
opsonizing zymosan. 
In the present study, we attempted to reconcile the differ-
ences in reported results by studying several different PMNL 
functions in the presence and absence of serum using two 
different stimuli . We found that lyzozyme release and super-
oxide generation were the same for psoriatic and normal PMNL 
in the absence of serum. An assay for PMNL phagocytosis that 
exp loits activation of the alternative complement pathway in 
autologous serum gave comparable results for psoriatics and 
controls. However, in the presence of 10% autologous serum, 
lysozyme release and o"- generation were significantly de -
creased when psoriatic PMNL were compared to normals. 
These data support the hypothesis that serum factor(s) exists 
in patients with psoriasis that may affect neutrophil functions. 
These factors may also play a role in the evolution and main-
tenance of the clinical manifestations of psoriasis. Further 
support for this concept derives from the recent demonstration 
that peritoneal dialysis can alter the course of refractory pso-
riasis [15]. If these hypothetical factors are not present in all 
psoriatic patients, the differences among the various studies of 
PMNL function may be explained on this basis. 
Recent interest has focused on the role of arachidonic acid 
metabolites of the 5- and 12-lipoxygenase pathways, monohy-
droxyeicosatetraenoic acids (HETEs), in the pathogenesis of 
psoriasis [16]. These highly chemotactic lipids have been found 
in scales [17], and soluble 5-lipoxygenase activity has been 
localized to the psoriatic epidermis [18] . Benoxaprofen, a potent 
inhibitor of 5-lipoxygenase, improved 75% of patients in a 
double-blind trial [19]. The effects of purified HETEs on 
PMNL function have not yet been completely defined, but they 
did slightly inhibit baseline superoxide generation [20] and 
phagocytosis-associated chemiluminescence [21] at chemotac-
tic concentrations. Whether elevated levels of HETEs in pso-
riatic serum could explain our observations is currently under 
investigation . 
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